期刊文献+

膀胱移行细胞癌患者尿脱落细胞中MUC7的表达及其临床意义的研究

MUC7 Expression in Cast-off Cells in Urine of Patients with Bladder Cancer
下载PDF
导出
摘要 目的:探讨膀胱移行细胞癌(BTCC)患者尿脱落细胞中MUC7的表达及其临床意义。方法:采用逆转录聚合酶链反应(RT-PCR)检测42例BTCC患者、40例对照者尿脱落细胞中MUC7的mRNA表达,β-actin作为内参照。结果:40例对照组中有2例MUC7 mRNA表达阳性,阳性率为5.0%;42例BTCC患者中36例尿脱落细胞中MUC7 mRNA表达阳性,阳性率为85.7%,其诊断特异性为95%。不同临床分期尿脱落细胞中MUC7 mRNA 的阳性表达率:Ta-T1期为64.3%(9/14),T2-4期为96.4%(27/28)。浸润性BTCC MUC7的阳性表达率显著高于浅表性BTEC(P<0.05)。不同病理分级BTCC患者尿脱落细胞中MUC7的mRNA的阳性表达率为C1 58.3%(7/ 12),C2 93.8%(15/16),G3 100%(14/14)。MUC7 mRNA的表达与BTCC的病理分级呈正相关。MUC7诊断BTCC 的阳性预测值为94.7%,阴性预测值为86.3%。结论:BTCC患者尿脱落细胞中MUC7的阳性表达率明显高于对照组。尿脱落细胞中MUC7表达与临床分期、病理分级呈正相关。采用RT-PCR法检测尿脱落细胞中MUC7表达诊断BTCC的敏感性和特异性好、阳性预测值高,特别对T2-4期肿瘤的诊断敏感性好。 Objective: To study the significance of Muc7 expression in cast-off ceils in the urine of patients with bladder transitimal cell carcinoma(BTCC). Methods: 42 patients with BTCC were collected in study group and 40 patients without BTCC (20 with urinary cancers other than bladder cancer, 10 with nonneoplastic uninary diseases, 10 healthy volunteers) in contrd group. RT-PCR method was used to detect Muc7 mRNA expression and β-actin as internal positive control in all cases. Results: Only 2 of 40(5% ) cases showed positive expression of Muc7 mRNA in control group. 36 of 42(85. 7% ) cases showed positivity in study group. The sensitivity and specificity of Muc7 examination for diagnosis of BTCC were 85.7% and 95% respectively. According to different clinical staging(Ta-T1 ,T2-4 ), the positive expression rats of Muc7 mRNA were 64. 3% (9/14) and 96.4% (27/28) respectively. The expression of Muc7 had a positive correlation with the cIinical staging of BTCC. As for the pathological grade of BTCC, the positive expression rates of Muc7 mRNA were 58. 3% in G1, 93.8% in G2, 100% in G3 respectively. The mRNA expression of Muc7 was positively correlated with the pathologic grade of BTCC. The positive and negative predictive values for diagnosis of BTCC were 94. 7% and 86. 3% respectively. Conclusions: I. The positive expression rate of Muc7 in cast-off cells in urine of patients with BTCC is 85.7%, which is significantly higher than that in control group( P 〈 0.05 ) ; 2. Expression of Muc7 is positviely correlated with the staging and grading of BTCC ; 3. Detecting Muc7 expression with RT-PCR method for diagnosis of BTCC is a method with high sensitivity, specificity and positive predictive value.
出处 《四川肿瘤防治》 2006年第1期5-8,共4页 Sichuan Journal of Cancer Control
关键词 膀胱肿瘤 MUC7 逆转录聚合酶链反应 尿脱落细胞 Bladder Transitional Cell Carcinoma MUCT Reverse Transcriptase-polymerase Chain Reaction Cast-off Cells in Unine
  • 相关文献

参考文献10

  • 1Dreller MJ. Bladder Cancer. State of the art cancer [ J ]. CA Cancer J Clin. 1998,48(5) :269-284.
  • 2Grossman HB. New methods for detection of blader cancer[j].Semin Urol Oncol, 1998,16( 1 ):17-22.
  • 3Ramakumar S, Bhniyan J, Besse JA, et al. Comparison of Screening methods in the detection of bladder cancer[J]. J Urol,1999,161 (2) :388-394.
  • 4Brown FM. Urine cytology: it is still the gold standard for screening[J]. Urol Clin North Am, 2000,27:25-37.
  • 5Lesuffeur T, Z Welbanm A, Real FX. Mucins in normal and neoplastic human gastrointestinal tissues[J]. Grit Rev Oncel Hernatol; 1994,17:153-180.
  • 6Hansk L, Hofmeier M, Schmitt-Graff A, et al. Over Expression or ectopic expression of Muc2 is the common property of mncinous carcinomas of the colon, pancreas, breast, and ovary[J]. J Pathol, 1997,182:385-391.
  • 7Huben RP. Tumor markers in bladder cancer[J]. Urolgy, 1984,23(3) :10-14.
  • 8吴小候,罗春丽.膀胱癌尿脱落细胞CK20表达的临床意义[J].中华泌尿外科杂志,2002,23(4):215-217. 被引量:8
  • 9Retz M, Lehmann JE. Muein7 and eytokeratin 20 as new diagnostic urinary markers for bladder tumor[ J]. J Urol, 2003,169:86-89.
  • 10Walsh MD, Hohn BG, Thong W, et al. Mucins expression by transitional cell carcinomas of the bladder[J]. Br J Urol, 1994,73:256- 262.

二级参考文献5

  • 1Moll R,Lowe A,Laufer J,et al.Cytokeratin 20 in human carcinomas-a new histodiagnositic marker.Am J Pathol,1992,140:427- 447.
  • 2Harnden P,Eardley I,Joyce A.D,et al.Cytokeratin 20 as an objective marker of urothelial dysplasia.Br J Urol,1996,78:870-875.
  • 3Klein A,Zemer R,Buchumensky V,et al.Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.Am Cancer,1998,82:349-354.
  • 4Harnden P,Mahmood N,Southgate J.Expression of cytokeratin 20 redefines urothelial papillomas of the bladder.Lancet ,1999,353:9157.
  • 5刘冉.细胞角蛋白20及其在肿瘤诊断中的应用[J].国外医学(肿瘤学分册),1998,25(1):14-16. 被引量:4

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部